RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
Conditions
Generalized Anxiety Disorder
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Lighthouse Psychiatry, Gilbert, Arizona, United States
Preferred Research Partners, Inc., Little Rock, Arkansas, United States
Collaborative Neuroscience Research, LLC, Garden Grove, California, United States
Kadima Neuropsychiatry Institute, La Jolla, California, United States
Open Mind Therapeutics, San Francisco, California, United States
TRIP Clinic at Psychedelic Science Institute, Santa Monica, California, United States
Innovative Clinical Research, Inc., Lauderhill, Florida, United States
University of South Florida, Tampa, Florida, United States
Atlanta Center for Medical Research, Atlanta, Georgia, United States
CenExel iResearch, LLC, Decatur, Georgia, United States
Uptown Research Institute, Chicago, Illinois, United States
Henry Ford Medical Center - Columbus, Novi, Michigan, United States
Midwest Research Group, Saint Charles, Missouri, United States
UNM Research Program Psychedelic Therapies, Albuquerque, New Mexico, United States
NYU-H+C Clinical and Translational Science Institute, New York, New York, United States
Neuro-Behavioral Clinical Research, Inc., North Canton, Ohio, United States
Summit Headlands LLC, Portland, Oregon, United States
Austin Clinical Trial Partners, Austin, Texas, United States
BioBehavioral Research Austion, Austin, Texas, United States
Aim Trials, LLC, Plano, Texas, United States
Cedar Clinical Research, Draper, Utah, United States
Inner Space State Street, Orem, Utah, United States
Study leads
Mark Pollack, M.D.
Study Director
Reunion Neuroscience Inc